Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-14, Stock:JNJ, The news for the past five days is as follows:
2019-10-07: NEWS1: Walmart, Travelers share losses lead Dow's nearly 50-point fall.NEWS2: Theravance Pipeline Strong, Dependence on Yupelri a Concern.NEWS3: The Zacks Analyst Blog Highlights: J&J, AstraZeneca, Roche, Glaxo and Merck.NEWS4: Johnson & Johnson Releases Inaugural You Belong: Diversity & Inclusion Impact Review.
2019-10-08: NEWS1: UPDATE 3-Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal.NEWS2: Johnson & Johnson (JNJ) Stock Moves -0.99%: What You Should Know.NEWS3: J&J must pay $8 bln in case over male breast growth linked to Risperdal -jury.NEWS4: [video]Johnson & Johnson Shares Fall After Hours on $8 Billion Jury Award.NEWS5: Is Johnson & Johnson (JNJ) A Good Stock To Buy According To Hedge Funds?.NEWS6: Teen beauty spending plunges 20% from last year to a 9-year low.NEWS7: Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline.NEWS8: Johnson & Johnson hit with $8bn court order over antipsychotic drug.
2019-10-09: NEWS1: Pharma Giant J&J Dips On $8 Billion Verdict Over Antipsychotic Drug.NEWS2: Johnson & Johnson -- Moody's: Risperdal verdict adds to J&J's litigation risk.NEWS3: Johnson & Johnson ordered to pay $8 billion in case tied to anti-psychotic drug.NEWS4: Top Trending: JNJ told to pay $8b to man over breast growth.NEWS5: US STOCKS-Tech stocks lift Wall St as reports brighten hopes of trade deal.NEWS6: JNJ Stock Gets A Boost After Settling Opioid Cases — But Should You Buy It?.NEWS7: Stocks - Wall Street Gains as Trade Tensions Ease a Little.NEWS8: J&J hit by "excessive" $8 bln verdict.NEWS9: J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case.NEWS10: Johnson & Johnson hit with $8 billion trial verdict.NEWS11: Tech investors need to brace for this pivotal $160 billion ‘gut punch’ in December, says analyst Dan Ives.NEWS12: Apple, U.S. Steel, Johnson & Johnson, PG&E, Lions Gate: Companies to Watch.NEWS13: Dow Jones Jumps 150 Points On China News; Apple, Roku Rally On Analyst Actions.NEWS14: Dow Jones Today: Stocks Bounce As China Seeks Trade War Truce; Apple Gets Price Target Hike.NEWS15: Massive jury award against J&J highlights risks of its legal strategy.NEWS16: Stocks - J&J Tumbles Premarket; American Outdoor Brands, Exxon Mobil Rise.NEWS17: [video]Buy Johnson & Johnson Amid $8 Billion Verdict.NEWS18: US STOCKS-Wall St eyes strong open as reports fuel trade deal hopes.NEWS19: Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit.NEWS20: Dow Jones Today: Futures Bounce As China Seeks Trade War Truce; Apple, Google Jump On 5G Rollout.NEWS21: Johnson & Johnson hit with $8B verdict over drug linked to boy growing breasts.NEWS22: FirstFT: Today’s top stories.NEWS23: [video]Dow Higher as China Signals Interest in Partial Trade Agreement.NEWS24: US STOCKS-Futures gain as reports fuel trade deal hopes.NEWS25: J&J Unit Ordered to Pay $8 Billion Over Anti-Psychotic Drug.NEWS26: Drugmakers in spotlight as GSK recalls Zantac.NEWS27: [video]Dow Climbs Ahead of Trade Talks as China Signals Interest in Partial Trade Pact.NEWS28: Stocks - Wall Street Opens Higher for First Time in Three Sessions.NEWS29: Johnson & Johnson Slides After $8 Billion Verdict in Pennsylvania Risperdal Case.NEWS30: China Trade Deal Optimism, J&J, Levi Strauss, PG&E - 5 Things You Must Know.NEWS31: Stocks - U.S. Futures Rise as China Offers to Buy American Agricultural Goods.NEWS32: Top 5 Things to Know in the Market on Wednesday.NEWS33: PRESS DIGEST- Wall Street Journal - Oct. 9.NEWS34: PRESS DIGEST- New York Times business news - Oct. 9.NEWS35: Johnson & Johnson hit with $8B verdict over drug linked to boy growing breasts.
2019-10-10: NEWS1: J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector.NEWS2: Company News For Oct 10, 2019.
2019-10-11: NEWS1: Why Johnson & Johnson Stock Can Weather Legal Awards Against It.NEWS2: What to Expect from Q3 Earnings Season with Big Banks Set to Report?.NEWS3: J&J CEO touts Philadelphia's potential to be the 'Silicon Valley of health care'.NEWS4: Johnson & Johnson Stock Has Limited Upside.NEWS5: Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals.NEWS6: Will Q3 Earnings Drive Dow ETF Higher?.NEWS7: J&J Rises After Analyst Calls Pharma Giant's Shares a Bargain.NEWS8: Geron Starts Enrollment in Phase III MDS Study on Imetelstat.NEWS9: The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout.

Answer: Decrease